Guggenheim Maintains Buy on CryoPort, Raises Price Target to $16
Guggenheim analyst Subbu Nambi maintains CryoPort (NASDAQ:CYRX) with a Buy and raises the price target from $12 to $16.
Stocks · News reference
CryoPort Q2 Adj. EPS $(0.20) Misses $(0.19) Estimate, Sales $48.971M Beat $48.207M Estimate
CryoPort (NASDAQ:CYRX) reported quarterly losses of $(0.20) per share which missed the analyst consensus estimate of $(0.19) by 5.26 percent. This is a 16.67 percent increase over losses of $(0.24) per share from the
Reference Details
Connected Markets
Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.
- Source
- benzinga
- Observed
- Checked
- Cadence
- Captured once, then retained as an archive reference
- Status
- fresh
Keep reading
Related Headlines
CryoPort shares are trading higher after the company reported better-than-expected Q2 sales results. Also, Needham maintained a Buy rating on the stock and raised its price target from $15 to $19.
Needham Maintains Buy on CryoPort, Raises Price Target to $19
Needham analyst David Saxon maintains CryoPort (NASDAQ:CYRX) with a Buy and raises the price target from $15 to $19.
Conference Call: CryoPort Affirms FY2026 Sales Guidance of $192.000M-$196.000M vs $194.390M Est
CryoPort (NASDAQ:CYRX) affirms FY2026 sales outlook from $192.000 million-$196.000 million to $192.000 million-$196.000 million vs $194.390 million estimate.